###begin article-title 0
Retinol-Binding Protein 4 in Twins
###end article-title 0
###begin p 1
###xml 43 56 43 56 <email xmlns:xlink="http://www.w3.org/1999/xlink">rrma@steno.dk</email>
Corresponding author: Rasmus Ribel-Madsen, rrma@steno.dk
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
OBJECTIVE-Retinol-binding protein (RBP) 4 is an adipokine of which plasma levels are elevated in obesity and type 2 diabetes. The aims of the study were to identify determinants of plasma RBP4 and RBP4 mRNA expression in subcutaneous adipose tissue (SAT) and skeletal muscle and to investigate the association between RBP4 and in vivo measures of glucose metabolism.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
RESEARCH DESIGN AND METHODS-The study population included 298 elderly twins (aged 62-83 years), with glucose tolerance ranging from normal to overt type 2 diabetes, and 178 young (aged 25-32 years) and elderly (aged 58-66 years) nondiabetic twins. Peripheral and hepatic insulin sensitivity was assessed by a euglycemic-hyperinsulinemic clamp, and beta-cell function was estimated from an intravenous glucose tolerance test.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 470 474 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 725 729 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
RESULTS-The influence of environmental versus genetic factors in the regulation of plasma RBP4 increased with age. Plasma RBP4 was elevated in type 2 diabetes and increased with duration of disease. Plasma RBP4 correlated inversely with peripheral, but not hepatic, insulin sensitivity. However, the association disappeared after correction for covariates, including plasma adiponectin. Plasma retinol, and not RBP4, was inversely associated with insulin secretion. SAT RBP4 expression correlated positively with GLUT4 expression and inversely with glucose tolerance. Skeletal muscle RBP4 expression reflected intramuscular fat, and although it was suppressed by insulin, no association with insulin sensitivity was evident. RBP4 expression was not associated with circulatory RBP4.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-In conclusion, our data indicate that RBP4 levels in plasma, skeletal muscle, and fat may be linked to insulin resistance and type 2 diabetes in a secondary and noncausal manner.
###end p 6
###begin p 7
Published ahead of print at  on 13 October 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
Retinol-binding protein (RBP) 4 is a transport protein for retinoids such as vitamin A in the blood (1). It is mainly produced in the liver but has recently been identified as an adipokine (2,3). The adipose tissue source, which secretes RBP4 into the circulation, may predominantly be visceral fat, including tissue (i.e., hepatic) fat depots (4,5). Recently, RBP4 expression has been detected in skeletal muscle, and RBP4 was accordingly suggested to be a myokine (6,7).
###end p 9
###begin p 10
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
Plasma RBP4 concentration may be under the influence of age and obesity (8,9). In addition, genes could play a role in determination of plasma RBP4, since certain single nucleotide polymorphisms in the RBP4 gene promoter have been shown to be associated with elevated plasma RBP4 (10). Nevertheless, little is known about the relative importance of genes versus environmental factors in determination of plasma RBP4.
###end p 10
###begin p 11
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 798 802 798 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis-</italic>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 1021 1023 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 1087 1089 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 1178 1183 1178 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PEPCK</italic>
###xml 1190 1191 1190 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 1279 1283 1279 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 827 833 <span type="species:ncbi:9606">humans</span>
Elevated plasma RBP4 levels have been observed in subjects with insulin resistance and type 2 diabetes (4,5,8,9,11,12). Downregulation of adipocyte GLUT4, causing impaired glucose uptake, is thought to represent a mechanism for upregulation of RBP4 secretion (3,13). An intervention study (3) in rodents has demonstrated that lowering of plasma RBP4 ameliorates insulin resistance. Thus, RBP4 may be a putative drug target for treatment of type 2 diabetes. The cellular mechanisms of action of RBP4 are largely unknown and may be mediated by the protein itself as well as its carried retinoids. It has long been known that vitamin A is involved in the regulation of metabolism. Vitamin A depletion may enhance hepatic oxidation of citric acid cycle intermediates (14), whereas administration of 13-cis-retinoic acid to healthy humans has been shown to induce reversible insulin resistance, including reduced glucose oxidation (15). Retinoids act as regulators of gene transcription through a series of nuclear receptors (16). Among others, the gene for PEPCK is controlled by retinoids (17), and it has been demonstrated that injection of RBP4 causes an upregulation of hepatic PEPCK mRNA (3). In the present study, we aimed to investigate determinants of plasma RBP4 as well as RBP4 mRNA expression in adipose tissue and skeletal muscle tissue and their influences on in vivo glucose metabolism.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin p 13
###xml 48 49 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 116 117 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 596 597 596 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
Population 1 consisted of 298 monozygotic (MZ) (n = 126, 49 pairs and 28 single twins) and same-sex dizygotic (DZ) (n = 172, 56 pairs and 60 single twins) elderly twins aged 62-83 years (18,19). Oral glucose tolerance test (OGTT) data were obtained in 295 subjects for which glucose tolerance status ranged from normal (n = 170) over impaired glucose tolerance (n = 83) to overt type 2 diabetes (n = 42). A total of 22 subjects had known type 2 diabetes and were treated with diet or glucose-lowering medication. Population 2 included 178 MZ (n = 97, 48 pairs and 1 single twin) and same-sex DZ (n = 81, 40 pairs and 1 single twin) twins without type 2 diabetes divided into two age-groups (aged 25-32 and 58-66 years) (20). Zygosity was determined by a questionnaire concerning phenotypic similarities (18) and, in population 2, additionally by polymorphic genetic markers (21). The study was approved by the regional ethical committees and conducted in accordance with the Helsinki Declaration.
###end p 13
###begin title 14
Clinical examination.
###end title 14
###begin p 15
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 363 364 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 589 590 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 590 591 590 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 1028 1029 1021 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1029 1031 1022 1024 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i1</sub>
###xml 1034 1036 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 1082 1083 1075 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 1083 1084 1076 1077 <sc xmlns:xlink="http://www.w3.org/1999/xlink">o</sc>
###xml 1084 1088 1077 1081 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2max</sub>
###xml 1147 1149 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
Both populations underwent measures of height and weight for calculation of BMI and a 75-g OGTT. In addition, subjects in population 2 underwent a dual-energy X-ray absorptiometry scan with measurement of total body fat percentage (22). Peripheral insulin sensitivity was determined by a 2-h (40 mU/m2 per min) euglycemic-hyperinsulinemic clamp, which included 3-3H-glucose infusion for measurement of hepatic glucose production (HGP), and indirect calorimetry for measurements of glucose oxidation (GOX) and fat oxidation (FOX) rates (20,23,24). Insulin-stimulated glucose disposal rate (Rd) and HGP were calculated by Steele's equations for non-steady state (25). Hepatic insulin sensitivity was assessed as the absolute difference in HGP between the basal state and upon insulin infusion (DeltaHGP) and as hepatic insulin sensitivity index (i.e., basal HGP multiplied by fasting plasma insulin). beta-Cell function was estimated from an intravenous glucose tolerance test by calculation of the first-phase disposition index (Di1) (20). Finally, physical fitness was estimated as Vo2max calculated from the maximal load on an ergometer bicycle (26).
###end p 15
###begin title 16
Tissue biopsies.
###end title 16
###begin p 17
###xml 106 107 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 257 258 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
Subcutaneous adipose tissue (SAT) biopsies were collected from the abdomen in a subgroup of population 1 (n = 196). Skeletal muscle biopsies were obtained from the vastus lateralis muscle before and during insulin stimulation in a subgroup of population 2 (n = 96) (23). The tissue specimens were taken under local anesthesia (lidocaine) using a Bergstrom needle with suction applied and were quickly blotted on filter paper and frozen in liquid nitrogen.
###end p 17
###begin title 18
Analytical methods.
###end title 18
###begin p 19
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 1178 1179 1176 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1188 1189 1186 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1276 1278 1274 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 1454 1455 1446 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1464 1465 1456 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1727 1729 1715 1717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 1730 1732 1718 1720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 671 674 <span type="species:ncbi:9685">cat</span>
###xml 795 806 <span type="species:ncbi:3704">horseradish</span>
###xml 830 836 <span type="species:ncbi:9986">rabbit</span>
###xml 1664 1669 <span type="species:ncbi:9606">human</span>
Plasma glucose was measured by the glucose dehydrogenase oxidation method (20). Fasting levels of plasma RBP4 were determined by enzyme-linked immunosorbent assay (ELISA) (27). The ELISA results were validated by Western blotting. A total amount of 0.2 mul plasma was diluted 1:100 and loaded in 10 mul of loading buffer (LDS sample buffer; Invitrogen, Carlsbad, CA) and 1 mol/l dithiothreitol mixed 5:2 on 10% Bis-Tris gels (Invitrogen). Electrophoresis in NuPAGE MES running buffer (Invitrogen) and blotting in NuPAGE transfer buffer were conducted according to the manufacturer's recommendations. The membrane was incubated overnight in polyclonal anti-RBP4 antibody (cat. no. A0040; Dako, Glostrup, Denmark) diluted 1:500. Detection and membrane development were performed with a polyclonal horseradish peroxidase-linked anti-rabbit antibody (Cell Signaling, Danvers, MA) diluted 1:2,000 and LumiGLO reagent (Cell Signaling). Imaging and protein quantification were carried out by means of an LAS-3000 Image Reader (FujiFilm, Tokyo, Japan) and MultiGauge 2.0 software (FujiFilm). The agreement between plasma RBP4 quantities measured by ELISA and Western blotting was good (r = 0.76, P < 0.001). Fasting plasma retinol was measured by high-pressure liquid chromatography (28). In all 468 plasma samples analyzed, mean RBP4 was 2.58 +/- 0.70 mumol/l, whereas mean retinol was 2.19 +/- 0.58 mumol/l. RBP4 and retinol concentrations correlated tightly (r = 0.93, P < 0.001). Fasting plasma interleukin-6 and tumor necrosis factor-alpha levels were measured by Quantikine ELISA kits (R&D systems, Minneapolis, MN), and fasting plasma adiponectin was measured by a human adiponectin ELISA kit (Linco Research, St. Charles, MO) (29,30).
###end p 19
###begin p 20
###xml 308 312 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 314 319 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 325 331 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ</italic>
###xml 492 496 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 514 519 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 541 547 539 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ</italic>
###xml 638 642 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA</italic>
Total RNA was isolated from skeletal muscle and SAT with TRI reagent (Sigma-Aldrich, St. Louis, MO). Random-hexamer primed reverse-transcription reactions were performed from 1 mug of total RNA in 100 mul of water using a RevertAid first-strand cDNA synthesis kit (Fermentas Life Sciences, Ontario, Canada). RBP4, GLUT4, and ADIPOQ (adiponectin) cDNA was quantified by TaqMan real-time PCR on an ABI Prism 7900 HT system (Applied Biosystems, Foster City, CA) using gene expression assays for RBP4 (Hs00198830_m1), GLUT4 (Hs00168966_m1), and ADIPOQ (Hs00605917_m1). The mRNA quantities of target genes were normalized to the mRNA level of PPIA (cyclophilin A) (4326316E) and expressed in arbitrary units (AU). The reactions were performed with 20-80 ng of cDNA in 4.5 mul of water, 0.5 mul of gene expression assay, and 5 mul of Universal PCR Master Mix (Applied Biosystems).
###end p 20
###begin title 21
Statistical methods
###end title 21
###begin title 22
Mixed ANOVA.
###end title 22
###begin p 23
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
Uni- and multivariate analyses were conducted using the PROC MIXED procedure in SAS (version 9.1; SAS Institute, Cary, NC), with adjustment for zygosity and intra-twin pair relationships (23). Furthermore, adjustment for sex, age, obesity, and physical fitness was performed. Before analysis, the response variable was transformed by natural logarithm.
###end p 23
###begin title 24
Correlation analyses.
###end title 24
###begin p 25
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 352 353 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 353 355 353 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MZ</sub>
###xml 358 359 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 359 361 359 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink">DZ</sub>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
Pearson or Spearman correlation coefficients were calculated. The total phenotypic variance is the sum of the variance attributable to effects of both genetic and environmental factors. The heritability (h2) expresses the proportion of variance attributable to genetic variance and was calculated from intraclass correlations in MZ and DZ twins [h2 = (rMZ - rDZ) x 2] (31).
###end p 25
###begin title 26
Data presentation.
###end title 26
###begin p 27
###xml 134 135 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data are presented as means +/- SD. Parameter estimates are shown in percentage with 95% CIs. Statistical significance was defined as P < 0.05.
###end p 27
###begin title 28
RESULTS
###end title 28
###begin p 29
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Tables 1</xref>
###xml 13 14 13 14 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">2</xref>
Tables 1 and 2 summarize the characteristics including age, anthropometry, and plasma RBP4 and retinol of subjects from populations 1 and 2.
###end p 29
###begin title 30
Factors regulating circulating RBP4
###end title 30
###begin title 31
Age.
###end title 31
###begin p 32
###xml 147 148 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 255 256 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
In population 2, plasma RBP4 levels were significantly lower in young (45.8 +/- 11.6 mug/ml) compared with elderly (51.2 +/- 9.8 mug/ml) subjects (P = 0.009). When adjusted for sex and body fat percentage, age was an independent predictor of plasma RBP4 (P = 0.006).
###end p 32
###begin title 33
Sex.
###end title 33
###begin p 34
###xml 297 298 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 310 311 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 531 532 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 668 669 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Among elderly subjects in both populations 1 and 2, plasma RBP4 was slightly (though not significantly) higher in male subjects (population 1: 57.9 +/- 16.5 mug/ml; population 2: 52.9 +/- 9.4 mug/ml) than in female subjects (population 1: 54.0 +/- 13.6 mug/ml; population 2: 49.7 +/- 10.1 mug/ml; P = 0.09 and P = 0.2, respectively). Among young subjects, the differences in plasma RBP4 between male and female subjects reached the level of significance (male subjects: 50.1 +/- 10.8 mug/ml; female subjects: 39.8 +/- 10.1 mug/ml; P < 0.001). In addition, when adjusted for age and body fat percentage, sex was an independent predictor of plasma RBP4 in population 2 (P < 0.001).
###end p 34
###begin title 35
Heredity.
###end title 35
###begin p 36
###xml 88 89 88 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 89 91 89 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MZ</sub>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 101 103 101 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">DZ</sub>
###xml 112 113 112 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 251 252 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 252 254 252 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MZ</sub>
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 264 266 264 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink">DZ</sub>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 299 301 299 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink">MZ</sub>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 311 313 311 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink">DZ</sub>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 434 435 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
In population 1, the intraclass correlation coefficients were alike in MZ and DZ twins (rMZ = 0.52, rDZ = 0.35; P = 0.3). Similarly, in population 2, there were no statistically significant differences in intraclass correlations, neither among young (rMZ = 0.75, rDZ = 0.44; P = 0.09) nor elderly (rMZ = 0.40, rDZ = 0.53; P = 0.6) twins. The heritability estimates for plasma RBP4 were h2 = 0.63 for young twins from population 2 and h2 = 0.35 for elderly twins from population 1. A heritability estimate was not calculable for elderly twins from population 2 because of a higher intraclass correlation in DZ twins.
###end p 36
###begin title 37
Obesity.
###end title 37
###begin p 38
###xml 61 62 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 96 97 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 124 125 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 166 167 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 188 189 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 209 210 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 363 364 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 446 447 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 491 492 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 534 535 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 572 573 555 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 699 700 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 742 743 719 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 780 781 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 918 919 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 931 932 902 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Subjects were stratified according to BMI (lean: BMI <25 kg/m2, overweight: 25 </= BMI < 30 kg/m2, and obese: BMI >/=30 kg/m2). In population 1, plasma RBP4 in lean (n = 119), overweight (n = 134), and obese (n = 43) subjects was 52.4 +/- 14.8, 57.7 +/- 14.6, and 58.3 +/- 16.6 mug/ml, respectively, with a significant difference between lean and obese subjects (P = 0.003). In population 2, plasma RBP4 differed between lean and obese subjects (P = 0.004) within the young age-group (lean [n = 63]: 43.9 +/- 11.0 mug/ml; overweight [n = 25]: 48.5 +/- 12.0 mug/ml; obese [n = 4]: 58.9 +/- 10.8 mug/ml), whereas no difference in plasma RBP4 was seen in the elderly subjects stratified for BMI (lean [n = 26]: 50.5 +/- 10.5 mug/ml; overweight [n = 37]: 51.0 +/- 10.7 mug/ml; obese [n = 15]: 52.6 +/- 6.5 mug/ml). When adjusted for sex and age, BMI was a significant predictor of plasma RBP4 in both populations 1 and 2 (P = 0.02 and P = 0.005, respectively).
###end p 38
###begin title 39
Metabolic effects of circulating RBP4 and retinol
###end title 39
###begin title 40
Glucose tolerance.
###end title 40
###begin p 41
###xml 231 237 222 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 361 362 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 410 411 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 529 530 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 559 560 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 717 718 702 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Mean plasma RBP4 concentrations were higher in subjects with type 2 diabetes (63.7 +/- 19.4 mug/ml) and impaired glucose tolerance (55.1 +/- 14.2 mug/ml) compared with subjects with normal glucose tolerance (53.6 +/- 13.3 mug/ml) (Fig. 1), and the difference between subjects with normal glucose tolerance and type 2 diabetes achieved statistical significance (P < 0.001). Subjects with known type 2 diabetes (n = 22, 71.2 +/- 21.9 mug/ml) had significantly higher plasma RBP4 than subjects with newly diagnosed type 2 diabetes (n = 26, 58.2 +/- 16.2 mug/ml; P = 0.02). Additionally, RBP4 was positively associated with glucose tolerance (i.e., 2-h post OGTT plasma glucose levels), independent of sex, age, and BMI (P = 0.01).
###end p 41
###begin title 42
Peripheral insulin sensitivity.
###end title 42
###begin p 43
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 72 73 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 137 143 137 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 200 201 200 201 <sc xmlns:xlink="http://www.w3.org/1999/xlink">o</sc>
###xml 201 205 201 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2max</sub>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 247 248 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 357 358 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 358 359 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 568 569 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 569 570 565 566 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 611 612 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 623 624 619 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 711 712 707 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 712 713 708 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 836 837 828 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
In both young and elderly twins, plasma RBP4 correlated inversely with Rd (r = -0.30, P = 0.004 and r = -0.37, P = 0.001, respectively) (Fig. 2). When adjusted for sex, age, body fat percentage, and Vo2max, RBP4 was independently associated with Rd with an effect of -4.8% (-9.6 to -0.04) for a 1-SD increase in RBP4. The corresponding effect of retinol on Rd was -5.0% (-9.2 to -0.4) (P = 0.04). When plasma concentrations of tumor necrosis factor-alpha, interleukin-6, and adiponectin were introduced into the multivariate model, the independent association between Rd and plasma RBP4 or retinol disappeared (P = 0.3 and P = 0.07, respectively). In contrast, plasma adiponectin was positively associated with Rd, independent of sex, age, body fat percentage, plasma interleukin-6, plasma tumor necrosis factor-alpha, and plasma RBP4 (P < 0.001).
###end p 43
###begin p 44
###xml 92 93 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 311 312 311 312 <sc xmlns:xlink="http://www.w3.org/1999/xlink">o</sc>
###xml 312 316 312 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2max</sub>
###xml 374 375 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 598 599 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 629 630 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Plasma RBP4 correlated with insulin-stimulated rates of glucose and fat oxidation in young (r = -0.36, P < 0.001; and r = 0.24, P = 0.02, respectively) but not in elderly (r = -0.20, P = 0.08; and r = 0.14, P = 0.2, respectively) subjects. Nevertheless, after adjustment for sex, age, body fat percentage, and Vo2max, plasma RBP4 was a significant predictor of GOX and FOX (P = 0.02 and P = 0.007, respectively), with a -6.0% decrease (-11.0 to -1.0) in GOX and a 20.7% increase (5.8-35.7) in FOX for a 1-SD increase in RBP4. The similar effects of retinol on GOX and FOX were -4.9% (-9.4 to 0.01; P = 0.05) and 22.7% (3.0-49.9; P = 0.01), respectively.
###end p 44
###begin title 45
Hepatic insulin sensitivity.
###end title 45
###begin p 46
###xml 62 63 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 73 74 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 96 97 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 107 108 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 244 245 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 357 358 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 369 370 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 387 388 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 397 398 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
DeltaHGP correlated inversely with plasma RBP4 in both young (r = -0.27, P = 0.01) and elderly (r = -0.25, P = 0.03) twins. However, when adjusted for sex, age, and body fat percentage, plasma RBP4 was not an independent predictor of DeltaHGP (P = 0.5). There was no significant correlation between plasma RBP4 and hepatic insulin sensitivity index (young: r = -0.041, P = 0.7; elderly: r = 0.15, P = 0.2). Furthermore, plasma retinol was not associated with hepatic insulin sensitivity (data not shown).
###end p 46
###begin title 47
beta-Cell function.
###end title 47
###begin p 48
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1 3 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i1</sub>
###xml 44 45 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 55 56 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 354 355 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 355 357 355 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i1</sub>
###xml 359 360 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 474 475 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 475 477 475 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i1</sub>
Di1 correlated with plasma RBP4 in elderly (r = -0.30, P = 0.01) but not in young (r = -0.057, P = 0.6) subjects. However, the association disappeared upon adjustment for sex, age, and body fat percentage (P = 0.1). On the other hand, when replacing RBP4 with retinol in the multivariate analysis, retinol was independently and inversely associated with Di1 (P = 0.04). The effect of a 1-SD increase in plasma retinol was associated with a -9.2% decrease (-16.3 to -0.7) of Di1.
###end p 48
###begin title 49
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
Tissue RBP4 mRNA expression
###end title 49
###begin title 50
SAT.
###end title 50
###begin p 51
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 121 122 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 144 145 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 196 197 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 247 251 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 315 316 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 362 363 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 388 389 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 401 402 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 427 433 417 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
###xml 477 482 467 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 487 491 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 504 505 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 514 515 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 526 532 516 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 535 540 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 587 588 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 598 599 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 648 649 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 659 660 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 679 683 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 723 724 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 735 736 725 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 777 781 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 810 811 800 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 821 822 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
RBP4 mRNA expression was significantly higher in female subjects (n = 94, 1.09 +/- 0.50 AU) compared with male subjects (n = 78, 0.84 +/- 0.42; P < 0.001). Subjects with normal glucose tolerance (n = 94, 1.06 +/- 0.53 AU) had significantly higher RBP4 mRNA expression than subjects with impaired glucose tolerance (n = 49, 0.93 +/- 0.44 AU) and type 2 diabetes (n = 28, 0.79 +/- 0.31 AU; P = 0.01 and P < 0.001, respectively) (Fig. 3). There was a positive correlation between GLUT4 and RBP4 expression (r = 0.61, P < 0.001) (Fig. 4). GLUT4 expression was inversely associated with BMI (r = -0.40, P < 0.001) and with 2-h post-OGTT plasma glucose (r = -0.24, P = 0.002), whereas RBP4 expression did not correlate with BMI (r = -0.052, P = 0.5). No correlation was seen between RBP4 expression and plasma RBP4 (r = -0.12, P = 0.1).
###end p 51
###begin title 52
Skeletal muscle.
###end title 52
###begin p 53
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 134 135 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 162 163 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 187 188 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 237 238 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 275 276 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 322 326 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 386 387 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 396 397 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 410 411 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 420 421 412 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 494 495 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 504 505 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 516 522 508 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 570 575 562 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 580 584 572 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 627 628 619 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 638 639 630 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 652 653 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 664 665 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 688 692 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 812 813 800 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 824 830 812 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6</xref>
###xml 895 896 883 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 896 897 884 885 <sc xmlns:xlink="http://www.w3.org/1999/xlink">o</sc>
###xml 897 901 885 889 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2max</sub>
###xml 922 926 910 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 974 975 962 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 975 976 963 964 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 978 979 966 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1030 1034 1018 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 1077 1078 1065 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1089 1090 1077 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
RBP4 mRNA expression in skeletal muscle was significantly lower in male subjects (n = 51, 8.12 +/- 10.02 AU) than in female subjects (n = 45, 38.75 +/- 55.69 AU; P < 0.001) and in young (n = 34, 9.94 +/- 12.21 AU) compared with elderly (n = 62, 29.91 +/- 49.47 AU) subjects (P = 0.02). In both young and elderly subjects, RBP4 expression correlated positively with body fat percentage (r = 0.37, P = 0.03; and r = 0.41, P < 0.001, respectively) and with skeletal muscle adiponectin expression (r = 0.86, P < 0.001) (Fig. 5). No significant correlation was found between GLUT4 and RBP4 expression in young and elderly subjects (r = -0.32, P = 0.08; and r = -0.074, P = 0.6, respectively). RBP4 expression was significantly reduced upon insulin stimulation (basal: 22.48 +/- 41.53 AU, insulin: 11.68 +/- 18.54 AU; P = 0.004) (Fig. 6). However, when adjusted for sex, age, body fat percentage, and Vo2max, insulin-stimulated RBP4 expression was not an independent predictor of Rd (P = 0.4). No correlation was observed between basal RBP4 expression and plasma RBP4 concentration (r = 0.0090, P = 0.9).
###end p 53
###begin title 54
DISCUSSION
###end title 54
###begin p 55
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
Elevated plasma RBP4 has been found to be associated with insulin resistance and type 2 diabetes in some (4,5,8,9,11,12), but not all (32-35), studies. The present study takes a step further in the investigation of the role of RBP4 as a mediator of insulin resistance. The unique twin study design combined with detailed metabolic characterization as well as eligible tissue specimens made it possible to explore areas that have not been fully covered previously. These include the relative influence of genes versus environment on circulating RBP4, the putative role of RBP4 as a myokine, and, finally, the influence of RBP4 on distinct in vivo measures of glucose metabolism.
###end p 55
###begin title 56
Regulating factors of plasma RBP4.
###end title 56
###begin p 57
###xml 372 376 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
The relative importance of genetic versus environmental etiological factors was determined by an estimate of heritability, which is the proportion of variance attributed to genetic factors. In the young twins, the heritability for plasma RBP4 was 63%, indicating a genetic component, which is in accordance with previous findings of an association between variants of the RBP4 gene and plasma RBP4 levels (10). Interestingly, the genetic influence declined with advancing age, suggesting that environmental factors may be the predominant regulator of plasma RBP4 in the elderly.
###end p 57
###begin p 58
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 1051 1052 1051 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
Male subjects had higher plasma RBP4 levels than female subjects, which is consistent with previous findings (4,8). The sex-specific difference in plasma RBP4 concentration seemed to decrease with age. Thus, among young twins, the plasma RBP4 concentration was 26% higher in male than in female subjects, whereas in elderly subjects, the difference was only 6-7%. It may be speculated that the greater difference in plasma RBP4 between male and female subjects in young compared with elderly subjects could be due to an influence of, and possibly regulation by, sex hormones, although oral contraception has been demonstrated to elevate plasma RBP4 (36). A relatively larger age-related increase in plasma RBP4 in female subjects than in male subjects could also be due to an alteration in body fat distribution toward android shape in aging female subjects. Elderly subjects had 12% higher plasma RBP4 concentration than young subjects. The fact that aging seemed to play a role in determination of plasma RBP4 is in agreement with a previous study (8).
###end p 58
###begin p 59
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r41">41</xref>
Obesity, as expressed by BMI, has previously been shown to be positively associated with plasma RBP4 (9,37). In accordance, we demonstrated 4-34% higher plasma RBP4 in obese compared with lean subjects, depending on twin population. Importantly, the association between overall obesity and plasma RBP4 was independent of sex and age. It has been demonstrated that particularly hepatic fat accumulation may lead to elevation of plasma RBP4 (5,38). Supporting this theory, we found a positive association between plasma levels of alanine amminotransferase and RBP4 (data not shown). In addition to genes, sex, and obesity, factors such as lipid metabolism (32), inflammation (39), hepatic function (40), and renal function (41) may influence plasma RBP4 levels. These areas were not investigated in the present study.
###end p 59
###begin title 60
Plasma RBP4 and in vivo glucose metabolism.
###end title 60
###begin p 61
Molar plasma concentrations of RBP4 and retinol correlated tightly, and therefore associations to metabolic rates were almost identical for RBP4 and retinol. When stratifying according to glucose tolerance, we found that diabetic subjects had 19% higher plasma RBP4 concentration than subjects with normal glucose tolerance, and the multivariate analysis confirmed that plasma RBP4 predicted glucose tolerance independently of sex, age, and obesity. Plasma RBP4 may therefore represent a biomarker for impairment of glucose tolerance. Interestingly, plasma RBP4 was significantly higher in subjects with known type 2 diabetes (i.e., a longer duration of disease) than in subjects with newly diagnosed type 2 diabetes, possibly related to the higher plasma glucose levels in the former group. Hence, an upregulation of plasma RBP4 could be a secondary event to hyperglycemia.
###end p 61
###begin p 62
###xml 18 19 18 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 20 21 20 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 22 23 22 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 358 359 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 359 360 359 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r42">42</xref>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r43">43</xref>
Previous studies (4,5,9,12) have demonstrated an inverse association between RBP4 and peripheral insulin sensitivity as determined by the euglycemic-hyperinsulinemic clamp technique. In the present study, we confirm this association, independent of the known influencing factors, age, body fat percentage, and physical fitness. However, the association with Rd was markedly surpassed by plasma adiponectin, making it less likely that plasma RBP4 is a key determinant of peripheral glucose uptake. In contrast, the effect of plasma RBP4 on insulin-stimulated fat oxidation rate was noteworthy. It has been demonstrated that treatment of adipocytes with retinoic acid, a major retinol metabolite, led to decreased adipogenesis and increased fat oxidation (42). Thus, plasma RBP4 could, via delivery of retinol to the cells, stimulate fat oxidation, thereby decreasing glucose oxidation according to Randle's cycle (43).
###end p 62
###begin p 63
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PEPCK</italic>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 360 365 <span type="species:ncbi:9606">human</span>
It has been shown in rodents that elevation of plasma RBP4 was associated with an upregulation of HGP, which was ascribed to an increased expression of PEPCK (3). To our knowledge, the present study is the first to describe the relationship between plasma RBP4 and hepatic insulin sensitivity measured by the gold standard euglycemic-hyperinsulinemic clamp in human subjects. Importantly, these data do not support a role of plasma RBP4 or retinol in regulation of hepatic insulin sensitivity.
###end p 63
###begin p 64
###xml 72 73 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 73 75 73 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i1</sub>
###xml 199 201 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 357 358 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 358 360 355 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i1</sub>
Plasma retinol, but not RBP4, was an independent, negative predictor of Di1. It has previously been demonstrated that plasma RBP4 was associated with impaired beta-cell function in elderly subjects (34). Our data indicate that the observed association could be mediated by retinol. However, the fact that no association was found between plasma retinol and Di1 in young subjects contradicts a causal connection between plasma retinol and beta-cell failure.
###end p 64
###begin title 65
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
Skeletal muscle and adipose tissue RBP4 mRNA expression.
###end title 65
###begin p 66
###xml 37 38 37 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 574 578 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 776 781 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 786 790 786 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 927 928 927 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 989 993 989 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 1057 1061 1057 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 1191 1195 1191 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 1279 1283 1279 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
In accordance with a previous study (6), RBP4 expression in skeletal muscle was low compared with that in SAT (data not shown). Female subjects had significantly higher RBP4 expression than male subjects, and mRNA levels correlated with total body fat percentage and with skeletal muscle adiponectin mRNA expression. Female sex is associated with increased body fat percentage, including intramuscular fat depots (44), and adiponectin is almost exclusively expressed in adipocytes (45), hence representing a surrogate for adipose tissue. Therefore, it is plausible that the RBP4 expression level in skeletal muscle reflects the amount of intramuscular fat rather than RBP4 being a true myokine synthesized by the muscle fibers. The lack of correlation between skeletal muscle GLUT4 and RBP4 expression supports this theory. It has previously been demonstrated that intramuscular fat content is not associated with plasma RBP4 (5). Accordingly, we did not find a correlation between muscle RBP4 expression and plasma RBP4. The suppression of skeletal muscle RBP4 expression to 55% of the basal level upon insulin infusion suggested a connection between glucose metabolism and skeletal muscle RBP4 expression. However, we did not demonstrate a relationship between skeletal muscle RBP4 expression and peripheral insulin sensitivity.
###end p 66
###begin p 67
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r46">46</xref>
###xml 315 319 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r47">47</xref>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 539 543 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 614 615 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 670 674 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 784 788 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 958 962 958 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 1025 1029 1025 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 1256 1258 1256 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r48">48</xref>
###xml 1259 1261 1259 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r49">49</xref>
###xml 1366 1370 1366 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 1506 1510 1506 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 1534 1538 1534 1538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 1568 1570 1568 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r47">47</xref>
###xml 1637 1641 1637 1641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 1693 1695 1693 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
Adipocyte GLUT4 mRNA and GLUT4 protein have been shown to be downregulated in obese and type 2 diabetic subjects (46). In the present study, these data were confirmed at mRNA level. It has been hypothesized that the impaired glucose uptake in GLUT4-deficient adipocytes could lead to a compensatory upregulation of RBP4 (13). Accordingly, RBP4 expression has been shown to correlate inversely with GLUT4 expression in visceral fat (3,47). In the present study we demonstrated a relatively strong positive correlation between SAT GLUT4 and RBP4 expression, which is in line with findings from two previous studies (6,33). Furthermore, we observed significantly lower SAT RBP4 expression in diabetic subjects compared with subjects with normal glucose tolerance. This downregulation of RBP4 expression could be due to the hyperinsulinemia characterizing the diabetic and/or insulin-resistant state, parallel to our finding of an insulin-induced suppression of RBP4 expression in skeletal muscle. Female subjects had higher SAT RBP4 expression than male subjects, though the sex-specific difference was less pronounced than in skeletal muscle. Differential expression of adipokines in SAT and visceral adipose tissue has been demonstrated in several studies (48,49), hence their metabolic activity is thought to be different depending on fat depot. Accordingly, higher RBP4 expression has been observed in visceral compared with SAT, and the difference was reflected by a stronger association of visceral fat RBP4 expression than of SAT RBP4 expression with plasma RBP4 (47). In the present study, we did not find a correlation between SAT RBP4 expression and plasma RBP4 as previously reported (33).
###end p 67
###begin p 68
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 240 246 <span type="species:ncbi:9606">humans</span>
In conclusion, our data indicate that elevated plasma RBP4 in type 2 diabetes is a secondary and predominantly nongenetic phenomenon and that plasma RBP4, per se, plays only a minor, if any, role in the development of insulin resistance in humans. Plasma glucose and insulin may be involved in the regulation of RBP4 expression in SAT and skeletal muscle; however, these tissues do not contribute to a noteworthy degree to production of plasma RBP4.
###end p 68
###begin p 69
The study was supported by grants from the Danish Diabetes Association, the Danish Strategic Research Council, the Danish Medical Research Council, and EXGENESIS.
###end p 69
###begin p 70
No potential conflicts of interest relevant to this article were reported.
###end p 70
###begin p 71
We thank the subjects for their participation in the study. In addition, the technical assistance of Marianne Modest is gratefully acknowledged.
###end p 71
###begin title 72
REFERENCES
###end title 72
###begin p 73
###xml 124 125 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 167 168 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 202 203 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 211 212 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 269 270 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Plasma RBP4 and glucose tolerance. Plasma RBP4 concentration (means +/- SE) in subjects with normal glucose tolerance (NGT; n = 170), impaired glucose tolerance (IGT; n = 83), and type 2 diabetes (T2D; n = 42). P values are adjusted for twin pair and zygosity status. xP < 0.001 for normal glucose tolerance vs. type 2 diabetes.
###end p 73
###begin p 74
###xml 16 17 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 17 18 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Plasma RBP4 and Rd. Insulin-stimulated glucose disposal rate (Rd) as a function of plasma RBP4 in 90 young (gray circles) twins (r = -0.30, P = 0.004) and 77 elderly (black circles) twins (r = -0.37, P = 0.001).
###end p 74
###begin p 75
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Subcutaneous adipose tissue GLUT4 versus RBP4 expression. Paired GLUT4 and RBP4 mRNA expression values, normalized to PPIA (cyclophilin A) mRNA, in 141 twins. r = 0.61, P < 0.001.
###end p 75
###begin p 76
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 84 88 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 119 123 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA</italic>
###xml 214 215 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 256 257 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 291 292 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 300 301 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 358 359 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 429 430 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Subcutaneous adipose tissue RBP4 expression and glucose tolerance. Means +/- SE for RBP4 mRNA expression normalized to PPIA (cyclophilin A) mRNA expression is shown for subjects with normal glucose tolerance (NGT; n = 94), impaired glucose tolerance (IGT; n = 49), and type 2 diabetes (T2D; n = 28). P values are adjusted for twin pair and zygosity status. xP = 0.01 for normal glucose tolerance vs. impaired glucose tolerance; *P < 0.001 for normal glucose tolerance vs. type 2 diabetes.
###end p 76
###begin p 77
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 91 97 91 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOQ</italic>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA</italic>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Skeletal muscle adiponectin versus RBP4 expression. Paired log basal expression values for ADIPOQ (adiponectin) and RBP4 mRNA normalized to PPIA (cyclophilin A) mRNA expression in 96 twins (r = 0.86, P < 0.001).
###end p 77
###begin p 78
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 110 114 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RBP4</italic>
###xml 145 149 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA</italic>
###xml 196 197 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Insulin stimulation and muscle RBP4 expression. Means +/- SE for basal and insulin-stimulated skeletal muscle RBP4 mRNA expression normalized to PPIA (cyclophilin A) mRNA expression in 79 twins. xP = 0.004.
###end p 78
###begin p 79
Characteristics including age, anthropometry, and plasma RBP4 and retinol of subjects from population 1
###end p 79
###begin p 80
Data are means +/- SD unless otherwise indicated.
###end p 80
###begin p 81
Characteristics including age, anthropometry, and plasma RBP4 and retinol of subjects from population 2
###end p 81
###begin p 82
Data are means +/- SD unless otherwise indicated.
###end p 82

